BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9328372)

  • 1. Acute renal failure due to indinavir crystalluria and nephrolithiasis: report of two cases.
    Berns JS; Cohen RM; Silverman M; Turner J
    Am J Kidney Dis; 1997 Oct; 30(4):558-60. PubMed ID: 9328372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Crystalluria and nephrolithiasis during therapy with the protease inhibitor indinavir].
    Rickerts V; Kober A; Stille W
    Dtsch Med Wochenschr; 1997 Jun; 122(24):803. PubMed ID: 9229567
    [No Abstract]   [Full Text] [Related]  

  • 3. Symptomatic crystalluria associated with indinavir.
    Famularo G; Di Toro S; Moretti S; De Simone C
    Ann Pharmacother; 2000 Dec; 34(12):1414-8. PubMed ID: 11144699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indinavir crystalluria: identification of patients at increased risk of developing nephrotoxicity.
    Trainor LD; Steinberg JP; Austin GW; Solomon HM
    Arch Pathol Lab Med; 1998 Mar; 122(3):256-9. PubMed ID: 9823864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystalluria and urinary tract abnormalities associated with indinavir.
    Clayman RV
    J Urol; 1998 Aug; 160(2):633. PubMed ID: 9679944
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute tubulointerstitial nephritis attributable to indinavir therapy.
    Jaradat M; Phillips C; Yum MN; Cushing H; Moe S
    Am J Kidney Dis; 2000 Apr; 35(4):E16. PubMed ID: 10739809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urological management of indinavir-associated acute renal failure in HIV-positive patients.
    Kalaitzis C; Passadakis P; Giannakopoulos S; Panagoutsos S; Mpantis E; Triantafyllidis A; Touloupidis S; Vargemezis V
    Int Urol Nephrol; 2007; 39(3):743-6. PubMed ID: 17180736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ureteral obstruction secondary to indinavir in the pediatric HIV population.
    Noble CB; Klein LT; Staiman VR; Neu N; Hensle TW; Berdon WE
    Pediatr Radiol; 1998 Aug; 28(8):627-9. PubMed ID: 9716639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indinavir nephrolithiasis in warm climates.
    Bach MC; Godofsky EW
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Mar; 14(3):296-7. PubMed ID: 9117466
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of environmental temperature on incidence of indinavir-related nephrolithiasis.
    Martínez E; Leguizamón M; Mallolas J; Miró JM; Gatell JM
    Clin Infect Dis; 1999 Aug; 29(2):422-5. PubMed ID: 10476752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protease inhibitor-induced urolithiasis.
    Gentle DL; Stoller ML; Jarrett TW; Ward JF; Geib KS; Wood AF
    Urology; 1997 Oct; 50(4):508-11. PubMed ID: 9338723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anuria and acute renal failure resulting from indinavir sulfate induced nephrolithiasis.
    Witte M; Tobon A; Gruenenfelder J; Goldfarb R; Coburn M
    J Urol; 1998 Feb; 159(2):498-9. PubMed ID: 9649271
    [No Abstract]   [Full Text] [Related]  

  • 13. Is indinavir crystalluria an indicator for indinavir stone formation?
    Salahuddin S; Hsu YS; Buchholz NP; Dieleman JP; Gyssens IC; Kok DJ
    AIDS; 2001 May; 15(8):1079-80. PubMed ID: 11400000
    [No Abstract]   [Full Text] [Related]  

  • 14. Indinavir-associated asymptomatic nephrolithiasis and renal cortex atrophy in two HIV-1 infected children.
    van Rossum AM; Dieleman JP; Fraaij PL; Cransberg K; Hartwig NG; Gyssens IC; de Groot R
    AIDS; 2001 Sep; 15(13):1745-7. PubMed ID: 11546957
    [No Abstract]   [Full Text] [Related]  

  • 15. [Renal lithiasis due to indinavir].
    Fernández JM; Robles JE; Regojo JM; López J; Sánchez D; Arocena J; Rosell D; Zudaire JJ; Berián JM
    Rev Med Univ Navarra; 2002; 46(3):28-32. PubMed ID: 12685114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nephrolithiasis in a HIV infected patient treated with indinavir].
    Brzósko S; Hryszko T; Panasiuk B; Prokopowicz D; Myśliwiec M
    Przegl Lek; 2001; 58(6):528-9. PubMed ID: 11816748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephrolithiasis on indinavir.
    Prescrire Int; 1999 Feb; 8(39):22. PubMed ID: 10557573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonopaque crystal deposition causing ureteric obstruction in patients with HIV undergoing indinavir therapy.
    Blake SP; McNicholas MM; Raptopoulos V
    AJR Am J Roentgenol; 1998 Sep; 171(3):717-20. PubMed ID: 9725303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased prevalence and analysis of risk factors for indinavir nephrolithiasis.
    Saltel E; Angel JB; Futter NG; Walsh WG; O'Rourke K; Mahoney JE
    J Urol; 2000 Dec; 164(6):1895-7. PubMed ID: 11061951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Papillary necrosis associated with the HIV protease inhibitor indinavir.
    Dieleman JP; van der Feltz M; Bangma CH; Stricker BH; van der Ende ME
    Infection; 2001 Aug; 29(4):232-3. PubMed ID: 11545487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.